At the end of May the first brachytherapy operation for prostate cancer was held at the Medical Center named after Vladimir Avakyan in Yerevan with the participation of Bebig. The operation was conducted by MD, Professor of Urology Yervand Harutyunyan together with Oshchepkov V., Researcher of the Research Institute of Urology, Ministry of Health of the Russian Federation, MD, and a board member of the Association of Russian brachytherapists.

«The number of prostate cancer patients has been steadily increasing in Armenia. With the support of the specialists of Bebig Armenian medicine made a breakthrough in the use of nuclear technologies in the field of public health. The carrying out of such operations at our clinic is a priceless opportunity to provide high-tech medical aid to citizens of Armenia. We further plan to organize the operation of low-dose- rate brachytherapy using microsources of "Bebig"» - said Yervand Harutyunyan.

Brachytherapy is a highly effective method of prostate cancer treatment, in 98% of cases, completely wiping out the malignant disease. The main components of the operation are radiation microsources implanted along the perimeter of the tumor. Brachytherapy method has been widely used in Europe and America for over 20 years. In Russia, the low-dose-rate brachytherapy for prostate cancer was included into the list of high-tech medical care funded by the state under the program of state guarantees of free medical care to citizens of the Russian Federation. With early detection of cancer citizens of the Russian Federation may benefit from this treatment for free. "Today, the low-dose-rate brachytherapy for prostate cancer has been used in 26 medical centers across Russia. The capacities of our plant allow not only satisfying the needs of all institutions by 100%, but also to expand into new markets. In the nearest future we plan to supply our microsources in the Eurasian Union countries, including Armenia and Kazakhstan ", - said Bebig Director General Kirill Mayorov.